Stock ScreenerStock IdeasPositive Investor SentimentPositive Investor SentimentInvestor sentiment can often be a leading indicator of stock performance. Sentiment Rating incorporates analyst revisions, insider activity, and short interest.
Stock ScreenerStock IdeasPositive Investor Sentiment
Zen Rating: A + 1 more
Sentiment Rating: A + 1 more
| Ticker | Company | Exchange | Industry | Zen Rating | Market Cap | Price | 1d % | EBITDA | P/E | D/E | Country | DD Score |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BWAY | BRAINSWAY LTD | NASDAQ | Medical Devices | B | $614.12M | $15.68 | -0.82% | $11.46M | 78.40x | 0.55 | Israel | 39 |
| CAPL | CROSSAMERICA PARTNERS LP | NYSE | Oil & Gas Refining & Marketing | B | $811.51M | $21.28 | 0.81% | $187.81M | 20.66x | -10.13 | United States | 20 |
| CGNT | COGNYTE SOFTWARE LTD | NASDAQ | Software - Infrastructure | A | $735.17M | $10.06 | 0.80% | $18.26M | -1,006.00x | 1.42 | Israel | 29 |
| SCYX | SCYNEXIS INC | NASDAQ | Drug Manufacturers - Specialty & Generic | B | $47.79M | $1.07 | -3.60% | -$8.44M | -6.29x | 0.20 | United States | 33 |
| VTEX | VTEX | NYSE | Software - Application | A | $733.49M | $4.24 | 0.71% | $25.73M | 38.20x | 0.48 | Cayman Islands | 42 |
Upgrade to Premium to View More
Use the proven Zen Ratings quant model to find stocks with high potential to beat the market. Stocks Zen-Rated "A" have beaten the market by +32.52% annually. Learn More
Already have access to Premium? Sign In
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.